Avadel (AVDL) Up in Light Trading for August 4

Equities Staff  |

Today, Avadel Pharmaceuticals plc - ADR (NASDAQ:AVDL) gained $0.49 to finish the day Thursday at $5.18.

The company started at $4.65 and shares fluctuated between $5.25 and $4.65 with 571,740 shares trading hands.

Avadel is averaging 863,020 shares traded over the last 30 days. They have fell 41.96% YTD.

Avadel expects its next earnings on 2022-08-08.

For technical charts, analysis, and more on Avadel visit the company profile.

About Avadel Pharmaceuticals plc - ADR

Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

To get more information on Avadel Pharmaceuticals plc - ADR and to follow the company's latest updates, you can visit the company's profile page here: Avadel Pharmaceuticals plc - ADR's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks



Market Movers

Sponsored Financial Content